EMD Serono
Funding Profiles
Access available for Technion staff. Please sign in to see the Agency profiles (upper left corner)EMD Serono is the biopharmaceutical division of Merck KGaA, Darmstadt, Germany. EMD Serono offers leading brands in 150 countries to help patients with cancer, multiple sclerosis, infertility, endocrine, and metabolic disorders, as well as cardiovascular diseases. In the United States and Canada, EMD Serono operates as a separately incorporated subsidiary of Merck Serono.
EMD Serono discovers, develops, manufactures and markets prescription medicines of both chemical and biological origin in specialist indications. We have an enduring commitment to deliver novel therapies in our core focus areas of oncology, neurology, and immunology.
For more information, please visit www.emdserono.com
To learn more about other Grants for Innovation in other therapeutic areas, please visit: www.grantformultiplesclerosisinnovation.org; www.grantforgrowthinnovation.org.
Contact information:
The fund is not a competitive fund
web site: http://www2.grantforoncologyinnovation.org/EMDSerono/index.html